{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T09:07:45Z","timestamp":1746781665234},"reference-count":19,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,6,24]],"date-time":"2002-06-24T00:00:00Z","timestamp":1024876800000},"content-version":"vor","delay-in-days":84,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapeutic Apheresis"],"published-print":{"date-parts":[[2002,4]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold> We report on the case of a 45 year old male with focal segmental glomerulosclerosis (FSGS) in whom steroid\u2010resistant proteinuria was reduced rapidly by plasma exchange. In 1994, he was admitted to our hospital because of massive proteinuria of several years' duration. Renal biopsy confirmed the diagnosis of FSGS. Proteinuria was suppressed partially with the use of dipyridamole. Though oral prednisolone (PSL, 30 mg\/day) was effective initially, relapse occurred during PSL tapering. Doses of PSL up to 30 mg\/day or additional mizoribine were ineffective. The patient was readmitted for a trial of plasma exchange in April 2000. Four sessions of plasma exchange with albumin replacement over 2 weeks immediately reduced the proteinuria from 3.2 g\/day to 0.6 g\/day without any change in medication. After discharge, proteinuria remained suppressed for more than 6 months despite a reduction of PSL dose to 15 mg. The rapid and long lasting effect of plasma exchange in the present case argues for the role of a putative circulatory factor in the pathogenesis of proteinuria in FSGS.<\/jats:p>","DOI":"10.1046\/j.1526-0968.2002.00348.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T21:01:36Z","timestamp":1047502896000},"page":"174-177","source":"Crossref","is-referenced-by-count":1,"title":["Rapid and Persistent Reduction of Proteinuria Following Plasma Exchange in a Case of Steroid\u2010Resistant Focal Segmental Glomerulosclerosis"],"prefix":"10.1111","volume":"6","author":[{"given":"Eriko","family":"Ishii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaichiro","family":"Tamba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Masunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,6,24]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1681\/ASN.V103552","article-title":"\u201cThe FSGS Factor.\u201d Enrichment and in vitro effect of activity from focal segmental glomerulosclerosis plasma.","volume":"10","author":"Sharma M","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604043341402"},{"key":"e_1_2_4_4_2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1681\/ASN.V121143","article-title":"Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis.","volume":"12","author":"Candiano G","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_4_5_2","first-page":"91","article-title":"Possible therapeutic application of low density lipoprotein apheresis (LDL\u2010A) in conjunction with double filtration plasmapheresis (DFPP) in drug\u2010resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).","volume":"30","author":"Tojo K","year":"1988","journal-title":"Jpn J Nephrol"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.4009\/jsdt1985.25.1363"},{"key":"e_1_2_4_7_2","first-page":"1","article-title":"LDL adsorption improves the response of focal glomerulosclerosis to corticosteroid therapy.","volume":"50","author":"Yokoyama K","year":"1998","journal-title":"Clin Nephrol"},{"key":"e_1_2_4_8_2","first-page":"257","article-title":"Dose LDL\u2010apheresis in steroid\u2010resistant nephrotic syndrome effect prognosis.","volume":"9","author":"Muso E","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_4_9_2","first-page":"91","article-title":"Excellent antiproteinuric effect by LDL apheresis in a case with severe renal dysfunction due to focal segmental glomerulosclerosis.","volume":"38","author":"Iwahori T","year":"1996","journal-title":"Jpn J Nephrol"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.5.1037"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(99)00941-0"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1998.v32.pm9708606"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.6.1524"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80381-7"},{"key":"e_1_2_4_15_2","first-page":"282","article-title":"Plasmapheresis in the treatment of steroid resistant focal segmental glomerulosclerosis.","volume":"48","author":"Ginsburg DS","year":"1997","journal-title":"Clin Nephrol"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.1.78"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.11.2650"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.8.2013"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199401063300102"},{"key":"e_1_2_4_20_2","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1681\/ASN.V1092014","article-title":"Effect of protein A immunoadsorption in nephrotic syndrome of various etiologies.","volume":"10","author":"Esnault VM","year":"1999","journal-title":"J Am Soc Nephrol"}],"container-title":["Therapeutic Apheresis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1526-0968.2002.00348.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1526-0968.2002.00348.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T13:50:05Z","timestamp":1697291405000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1526-0968.2002.00348.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["10.1046\/j.1526-0968.2002.00348.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1526-0968.2002.00348.x","archive":["Portico"],"relation":{},"ISSN":["1091-6660","1526-0968"],"issn-type":[{"value":"1091-6660","type":"print"},{"value":"1526-0968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}